Nukkleus Inc. Reports Director Changes and Officer Appointments
Ticker: DFNSW · Form: 8-K · Filed: Dec 9, 2025 · CIK: 1787518
Sentiment: neutral
Topics: management-change, corporate-governance
Related Tickers: NUKK
TL;DR
Nukkleus Inc. board shakeup and new execs announced.
AI Summary
Nukkleus Inc. filed an 8-K on December 9, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and compensatory arrangements. The filing covers events as of December 8, 2025, and includes details about the company's common stock and warrants.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board and officer composition can indicate internal shifts that may affect company direction and stability.
Key Players & Entities
- Nukkleus Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- December 8, 2025 (date) — Earliest event reported
- December 9, 2025 (date) — Filing date
FAQ
What specific changes were made to the board of directors and officer positions?
The filing indicates a reportable event concerning the departure of directors, election of directors, and appointment of certain officers, but the specific names and details of these changes are not provided in the excerpt.
What is the exact date of the events reported in this 8-K?
The earliest event reported is dated December 8, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on December 9, 2025.
What are the details of the compensatory arrangements mentioned?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item information, but the specific details of these arrangements are not included in the provided text.
What is Nukkleus Inc.'s former company name?
Nukkleus Inc.'s former company name was Brilliant Acquisition Corp., with a date of name change on September 9, 2019.
Filing Stats: 614 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-12-09 16:30:39
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NUKK The Nasdaq
- $92.00 — sable for one Share of Common Stock for $92.00 per share NUKKW The Nasdaq Global M
- $7,500 — iary, Mr. Levi will receive a salary of $7,500 per month. There are no arrangements o
Filing Documents
- ea0268978-8k_nukkleus.htm (8-K) — 28KB
- 0001213900-25-119683.txt ( ) — 235KB
- nukk-20251208.xsd (EX-101.SCH) — 4KB
- nukk-20251208_def.xml (EX-101.DEF) — 26KB
- nukk-20251208_lab.xml (EX-101.LAB) — 36KB
- nukk-20251208_pre.xml (EX-101.PRE) — 25KB
- ea0268978-8k_nukkleus_htm.xml (XML) — 6KB
02 Departure of Directors or Certain Officers; Election of
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 8, 2025, the Board of Directors of Nukkleus Inc., a Delaware corporation (the "Company"), appointed Morel Levi as the Chief Financial Officer of the Company, effective as of December 8, 2025. Mr. Levi will also serve as the Chief Financial Officer of Nukk Picolo Ltd., a wholly owned subsidiary of the Company (the "Subsidiary"), and has entered into an employment agreement with the Subsidiary. Mr. Levi, age 33, has been the Financial Controller at the Subsidiary since August 1, 2025. Prior to his employment with the Subsidiary, Mr. Levi was the Controller at Blender Financial Technologies Ltd. from December 2022 through July 2025. Prior to his employment at Blender Financial Technologies Ltd., Mr. Levi worked at Kost Forer Gabbay & Kasierer (EY Israel) from October 2020 through November 2022. In connection with his appointment as Chief Financial Officer of the Company and Subsidiary, Mr. Levi will receive a salary of $7,500 per month. There are no arrangements or understandings between Mr. Levi and any other person pursuant to which he was selected to serve as the Chief Financial Officer of the Company and there are no family relationships between Mr. Levi and any director or executive officer of the Company. The Company has not entered into any transactions with Mr. Levi that are reportable pursuant to Item 404(a) of Regulation S-K. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NUKKLEUS INC. Date: December 9, 2025 By: /s/ Menachem Shalom Name Menachem Shalom Title: Chief Executive Officer 2